56 Results | Everything | Search

Displaying 1 - 25 of 56 Results

Rapamycin

An allosteric inhibitor of mTORC1

CAS No. 53123-88-9

Item No. 13346

Formulation: A crystalline solid

Purity: ≥95%

AY 22989
NSC 226080
Sirolimus
Wy 090217

1 mg

$43

Add

5 mg

$108

Add

10 mg

$194

Add

25 mg

$429

Add

Torin 1

Selective inhibitor of mTOR

CAS No. 1222998-36-8

Item No. 10997

Formulation: A crystalline solid

Purity: ≥95%

10 mg

$161

Add

25 mg

$363

Add

50 mg

$591

Add

PI-103

A potent, cell-permeable PI3-kinase inhibitor

CAS No. 371935-74-9

Item No. 10009209

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$33

Add

5 mg

$125

Add

10 mg

$186

Add

25 mg

$347

Add

NVP-BEZ235

A dual inhibitor of class I PI3Ks and mTOR

CAS No. 915019-65-7

Item No. 10565

Formulation: A crystalline solid

Purity: ≥98%

Dactolisib

25 mg

$49

Add

50 mg

$86

Add

100 mg

$152

Add

250 mg

$259

Add

INK128

Inhibitor of TORC1/2

CAS No. 1224844-38-5

Item No. 11811

Formulation: A crystalline solid

Purity: ≥98%

MLN0128

1 mg

$28

Add

5 mg

$49

Add

10 mg

$83

Add

50 mg

$275

Add

Torin 2

Selective inhibitor of mTOR

CAS No. 1223001-51-1

Item No. 14185

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$95

Add

10 mg

$178

Add

25 mg

$370

Add

Rapamycin-d₃

An internal standard for the quantification of rapamycin

CAS No. 392711-19-2

Item No. 22093

Formulation: A 1 mg/ml solution in ethanol

Purity: ≥98% deuterated forms (d₁-d₃)

Sirolimus-d₃

500 µg

$134

Add

1 mg

$202

Add

AZD 8055

A potent mTOR inhibitor

CAS No. 1009298-09-2

Item No. 16978

Formulation: A crystalline solid

Purity: ≥98%

CCG-168

1 mg

$49

Add

5 mg

$96

Add

10 mg

$143

Add

50 mg

$423

Add

PP242

Potent inhibitor of mTOR kinase in both mTORC1 and mTORC2

CAS No. 1092351-67-1

Item No. 13643

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$36

Add

5 mg

$91

Add

10 mg

$147

Add

25 mg

$319

Add

Everolimus-d₄

An internal standard for the quantification of everolimus

CAS No. 1338452-54-2

Item No. 22559

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₄); ≤1% d₀

500 µg

$160

Add

1 mg

$289

Add

CAY10626

A dual PI3Kα/mTOR kinase inhibitor

CAS No. 1202884-94-3

Item No. 13838

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$116

Add

5 mg

$521

Add

10 mg

$924

Add

25 mg

$1,877

Add

GSK2126458

A potent pan-PI3K and mTOR inhibitor

CAS No. 1086062-66-9

Item No. 17377

Formulation: A crystalline solid

Purity: ≥98%

GSK458
Omipalisib

1 mg

$54

Add

5 mg

$238

Add

10 mg

$418

Add

50 mg

$1,303

Add

Ku-0063794

An inhibitor of mTORC1 and mTORC2

CAS No. 938440-64-3

Item No. 13597

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$81

Add

10 mg

$152

Add

50 mg

$436

Add

100 mg

$633

Add

OSI-027

Dual mTORC1/mTORC2 inhibitor

CAS No. 936890-98-1

Item No. 17379

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$41

Add

5 mg

$148

Add

10 mg

$274

Add

50 mg

$737

Add

Wortmannin-Rapamycin Conjugate

Separate PI3K and mTORC1 inhibitors joined by prodrug linker

CAS No. 1067892-47-0

Item No. 13671

Formulation: A crystalline solid

Purity: ≥98%

500 µg

$168

Add

1 mg

$317

Add

5 mg

$1,325

Add

AZD 2014

A potent dual mTORC1/2 inhibitor

CAS No. 1009298-59-2

Item No. 17378

Formulation: A crystalline solid

Purity: ≥98%

Vistusertib

1 mg

$36

Add

5 mg

$103

Add

10 mg

$161

Add

25 mg

$336

Add

WYE-125132

Dual mTORC1/mTORC2 inhibitor

CAS No. 1144068-46-1

Item No. 18372

Formulation: A crystalline solid

Purity: ≥98%

WYE-132

500 µg

$41

Add

1 mg

$69

Add

5 mg

$106

Add

10 mg

$196

Add

17β-hydroxy Wortmannin

Inhibitor of phosphoinoside 3-kinase

CAS No. 58053-83-1

Item No. 13812

Formulation: A crystalline solid

Purity: ≥98%

500 µg

$65

Add

1 mg

$119

Add

5 mg

$493

Add

10 mg

$862

Add

PF-05212384

A potent, dual PI3K/mTOR inhibitor

CAS No. 1197160-78-3

Item No. 14567

Formulation: A crystalline solid

Purity: ≥95%

PK-1587
PKI-587

1 mg

$41

Add

5 mg

$178

Add

10 mg

$312

Add

AZD 3147

A dual mTORC1/mTORC2 inhibitor

CAS No. 1101810-02-9

Item No. 22474

Formulation: A solid

Purity: ≥95%

500 µg

$36

Add

1 mg

$61

Add

5 mg

$219

Add

10 mg

$303

Add

MK-8669

A rapamycin analog that selectively inhibits mTOR in mTORC1

CAS No. 572924-54-0

Item No. 10543

Formulation: A crystalline solid

Purity: ≥95%

AP23573
Deforolimus
Ridaforolimus

1 mg

$46

Add

5 mg

$202

Add

10 mg

$290

Add

WYE-28

An inhibitor of mTOR

CAS No. 1062172-60-4

Item No. 21200

Formulation: A crystalline solid

Purity: ≥98%

500 µg

$49

Add

1 mg

$93

Add

5 mg

$376

Add

10 mg

$655

Add

GDC-0980

A dual inhibitor of PI3K and mTOR

CAS No. 1032754-93-0

Item No. 18303

Formulation: A crystalline solid

Purity: ≥98%

Apitolisib
RG7422

1 mg

$69

Add

5 mg

$198

Add

10 mg

$329

Add

25 mg

$655

Add

WYE-354

Potent inhibitor of mTOR in both mTORC1 and mTORC2

CAS No. 1062169-56-5

Item No. 13604

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$103

Add

10 mg

$194

Add

25 mg

$454

Add

50 mg

$801

Add

PF-04691502

A PI3Kα, -β, -δ, -γ, and mTOR inhibitor

CAS No. 1013101-36-4

Item No. 15017

Formulation: A crystalline solid

Purity: ≥95%

HNC-VP-L
PF-502

5 mg

$98

Add

10 mg

$157

Add

25 mg

$367

Add

50 mg

$636

Add

Displaying 1 - 25 of 56 Results

Cart Subtotal:$0

Product TypeClear Filters

Research AreaClear Filters

ApplicationClear Filters

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A 1 mg/ml solution in ethanol

Purity: ≥98% deuterated forms (d1-d3)

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A solid

Purity: ≥99% deuterated forms (d1-d4); ≤1% d0

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Purity: ≥98% deuterated forms (d₁-d₃)

Purity: ≥99% deuterated forms (d₁-d₄); ≤1% d₀